| scholarly article | Q13442814 |
| P50 | author | Michael K O'Reilly | Q83836932 |
| Ciara Gillespie | Q89754827 | ||
| Grainne Allen | Q96273689 | ||
| P2093 | author name string | S McDermott | |
| C A Ridge | |||
| V O Chan | |||
| P2860 | cites work | Management of hepatocellular carcinoma: An update | Q27860530 |
| Cirrhosis and other liver disease in cystic fibrosis | Q28660820 | ||
| Genetic modifiers of liver disease in cystic fibrosis | Q30418279 | ||
| Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores | Q30465393 | ||
| Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis | Q33207601 | ||
| A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. | Q33377573 | ||
| Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances | Q33931659 | ||
| Scientific advances in cystic fibrosis | Q35328348 | ||
| Risk factors for chronic kidney disease in adults with cystic fibrosis. | Q35682983 | ||
| Review of the abdominal manifestations of cystic fibrosis in the adult patient | Q36479687 | ||
| The influence of genetics on cystic fibrosis phenotypes | Q36526522 | ||
| Liver manifestations of cystic fibrosis | Q36686402 | ||
| Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features | Q37163891 | ||
| Cystic fibrosis-associated liver disease | Q37801087 | ||
| Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease | Q37887181 | ||
| Features, diagnosis, and treatment of nonalcoholic fatty liver disease | Q37996848 | ||
| A review of renal disease in cystic fibrosis. | Q38101739 | ||
| A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver | Q38105838 | ||
| Management of comorbidities in older patients with cystic fibrosis. | Q38178773 | ||
| Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies | Q38207382 | ||
| Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients | Q38440699 | ||
| Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes | Q42042094 | ||
| Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome | Q78560745 | ||
| Liver cirrhosis and portal hypertension in cystic fibrosis | Q79075001 | ||
| Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease | Q81371688 | ||
| Factors increasing the risk for stone formation in adult patients with cystic fibrosis | Q83089813 | ||
| Hepatocellular carcinoma complicating cystic fibrosis related liver disease | Q83927255 | ||
| Ursodeoxycholic acid in cystic fibrosis-associated liver disease | Q84812621 | ||
| Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease? | Q42046506 | ||
| Metabolic risk factors for stone formation in patients with cystic fibrosis | Q43855844 | ||
| Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease | Q44022305 | ||
| Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease. | Q45089361 | ||
| ARFI and transient elastography for characterization of cystic fibrosis related liver disease: first longitudinal follow-up data in adult patients | Q45669424 | ||
| Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation. | Q45931061 | ||
| Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment | Q46179802 | ||
| Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis | Q46203257 | ||
| Advanced hepatocellular carcinoma associated with cystic fibrosis | Q47732089 | ||
| Outcome in patients with cystic fibrosis liver disease. | Q51134980 | ||
| Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study. | Q53928769 | ||
| Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy | Q57651838 | ||
| Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease | Q60589075 | ||
| Huge lipomatous pseudohypertrophy of the pancreas | Q66919375 | ||
| Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation | Q71603954 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 5128760 | |
| P577 | publication date | 2017-01-29 | |
| P1433 | published in | International Journal of Hepatology | Q26853849 |
| P1476 | title | Imaging the Abdominal Manifestations of Cystic Fibrosis | |
| P478 | volume | 2017 |
| Q92128583 | Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis |
| Q92006711 | Microgallbladder: Self-Remitting Acute Cholecystitis-Like Condition Unique to Patients with Cystic Fibrosis |
| Q49334378 | Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease |
Search more.